The global structural heart imaging market is projected to grow from USD 9.99 billion in 2025 to USD 16.76 billion by 2034, expanding at a CAGR of 5.91%. Growth is driven by the rising prevalence of congenital and lifestyle-related heart diseases, coupled with increasing adoption of minimally invasive procedures like TAVR.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Structural Heart Imaging Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Structural Heart Imaging Market, by Modality
8.1.1. Echocardiogram
8.1.1.1. Market Revenue and Forecast
8.1.2. Angiogram
8.1.2.1. Market Revenue and Forecast
8.1.3. CT
8.1.3.1. Market Revenue and Forecast
8.1.4. MRI
8.1.4.1. Market Revenue and Forecast
8.1.5. Nuclear Imaging
8.1.5.1. Market Revenue and Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Forecast
9.1. Structural Heart Imaging Market, by Procedure
9.1.1. Transcatheter Aortic Valve Replacement (TAVR)
9.1.1.1. Market Revenue and Forecast
9.1.2. Surgical Aortic Valve Replacement (SAVR)
9.1.2.1. Market Revenue and Forecast
9.1.3. Transcatheter Mitral Valve Repair (TMVR)
9.1.3.1. Market Revenue and Forecast
9.1.4. Left Atrial Appendage Closure (LAAC)
9.1.4.1. Market Revenue and Forecast
9.1.5. Annuloplasty
9.1.5.1. Market Revenue and Forecast
9.1.6. Valvuloplasty
9.1.6.1. Market Revenue and Forecast
9.1.7. Others
9.1.7.1. Market Revenue and Forecast
10.1. Structural Heart Imaging Market, by Application
10.1.1. Valvular Heart Disease
10.1.1.1. Market Revenue and Forecast
10.1.2. Congenital Heart Disease
10.1.2.1. Market Revenue and Forecast
11.1. Structural Heart Imaging Market, by End-use
11.1.1. Hospitals And Clinics
11.1.1.1. Market Revenue and Forecast
11.1.2. Ambulatory Surgical Centers
11.1.2.1. Market Revenue and Forecast
11.1.3. Diagnostic Imaging Centers
11.1.3.1. Market Revenue and Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Modality
12.1.2. Market Revenue and Forecast, by Procedure
12.1.3. Market Revenue and Forecast, by Application
12.1.4. Market Revenue and Forecast, by End-use
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Modality
12.1.5.2. Market Revenue and Forecast, by Procedure
12.1.5.3. Market Revenue and Forecast, by Application
12.1.5.4. Market Revenue and Forecast, by End-use
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Modality
12.1.6.2. Market Revenue and Forecast, by Procedure
12.1.6.3. Market Revenue and Forecast, by Application
12.1.6.4. Market Revenue and Forecast, by End-use
12.2. Europe
12.2.1. Market Revenue and Forecast, by Modality
12.2.2. Market Revenue and Forecast, by Procedure
12.2.3. Market Revenue and Forecast, by Application
12.2.4. Market Revenue and Forecast, by End-use
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Modality
12.2.5.2. Market Revenue and Forecast, by Procedure
12.2.5.3. Market Revenue and Forecast, by Application
12.2.5.4. Market Revenue and Forecast, by End-use
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Modality
12.2.6.2. Market Revenue and Forecast, by Procedure
12.2.6.3. Market Revenue and Forecast, by Application
12.2.6.4. Market Revenue and Forecast, by End-use
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Modality
12.2.7.2. Market Revenue and Forecast, by Procedure
12.2.7.3. Market Revenue and Forecast, by Application
12.2.7.4. Market Revenue and Forecast, by End-use
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Modality
12.2.8.2. Market Revenue and Forecast, by Procedure
12.2.8.3. Market Revenue and Forecast, by Application
12.2.8.4. Market Revenue and Forecast, by End-use
12.3. APAC
12.3.1. Market Revenue and Forecast, by Modality
12.3.2. Market Revenue and Forecast, by Procedure
12.3.3. Market Revenue and Forecast, by Application
12.3.4. Market Revenue and Forecast, by End-use
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Modality
12.3.5.2. Market Revenue and Forecast, by Procedure
12.3.5.3. Market Revenue and Forecast, by Application
12.3.5.4. Market Revenue and Forecast, by End-use
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Modality
12.3.6.2. Market Revenue and Forecast, by Procedure
12.3.6.3. Market Revenue and Forecast, by Application
12.3.6.4. Market Revenue and Forecast, by End-use
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Modality
12.3.7.2. Market Revenue and Forecast, by Procedure
12.3.7.3. Market Revenue and Forecast, by Application
12.3.7.4. Market Revenue and Forecast, by End-use
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Modality
12.3.8.2. Market Revenue and Forecast, by Procedure
12.3.8.3. Market Revenue and Forecast, by Application
12.3.8.4. Market Revenue and Forecast, by End-use
12.4. MEA
12.4.1. Market Revenue and Forecast, by Modality
12.4.2. Market Revenue and Forecast, by Procedure
12.4.3. Market Revenue and Forecast, by Application
12.4.4. Market Revenue and Forecast, by End-use
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Modality
12.4.5.2. Market Revenue and Forecast, by Procedure
12.4.5.3. Market Revenue and Forecast, by Application
12.4.5.4. Market Revenue and Forecast, by End-use
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Modality
12.4.6.2. Market Revenue and Forecast, by Procedure
12.4.6.3. Market Revenue and Forecast, by Application
12.4.6.4. Market Revenue and Forecast, by End-use
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Modality
12.4.7.2. Market Revenue and Forecast, by Procedure
12.4.7.3. Market Revenue and Forecast, by Application
12.4.7.4. Market Revenue and Forecast, by End-use
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Modality
12.4.8.2. Market Revenue and Forecast, by Procedure
12.4.8.3. Market Revenue and Forecast, by Application
12.4.8.4. Market Revenue and Forecast, by End-use
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Modality
12.5.2. Market Revenue and Forecast, by Procedure
12.5.3. Market Revenue and Forecast, by Application
12.5.4. Market Revenue and Forecast, by End-use
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Modality
12.5.5.2. Market Revenue and Forecast, by Procedure
12.5.5.3. Market Revenue and Forecast, by Application
12.5.5.4. Market Revenue and Forecast, by End-use
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Modality
12.5.6.2. Market Revenue and Forecast, by Procedure
12.5.6.3. Market Revenue and Forecast, by Application
12.5.6.4. Market Revenue and Forecast, by End-use
13.1. GE Healthcare
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Siemens Healthineers AG
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Koninklijke Philips N.V
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Canon Medical System, USA
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Boston Scientific Corporation
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Medtronic
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Edwards Lifesciences Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Bracco
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. FUJIFILM Holdings Corporations
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Hitachi, Ltd
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description